|
|
Effect of Omeprazole Combined with Clarithromycin and Metronidazole in the Treatment of Helicobacter Pylori Associated Gastritis in Children on the Level of Inflammatory Factors and Immune Function |
TIAN Jian-hong, ZHANG Xue-bo |
Department of Pediatrics, Sun Simiao Hospital, Beijing University of Chinese Medicine /Tongchuan Chinese Medicine Hospital, Tongchuan 727000, Shaanxi, China |
|
|
Abstract 【Objective】 To investigate the effect of omeprazole combined with clarithromycin and metronidazole in the treatment of Helicobacter pylori associated gastritis in children on the level of inflammatory factors and immune function.【Methods】 Eighty children with Helicobacter pylori associated gastritis in our hospital were selected and divided into control group and observation group according to different treatment methods, 40 cases in each group. The control group was treated with omeprazole + amoxicillin + metronidazole, and the observation group was treated with omeprazole + clarithromycin + metronidazole. The clinical effects of the two groups were analyzed.【Results】 The total effective rate of the observation group was 95.00% (38/40), which was significantly higher than 77.50% (31 / 40) of the control group (χ2=5.165,P=0.023<0.05). The disappearance time of abdominal pain in the observation group was shorter than that in the control group (P<0.05). The eradication rate of HP in the observation group was higher than that in the control group, but there was no significant difference between the two groups (χ2=1.829, P>0.05). After treatment, the levels of CD3+ , CD4+, CD4+/CD8+ in the observation group were higher than those in the control group, and the level of CD8+ in the observation group was lower than that in the control group (P<0.05). After treatment, the level of serum TGF-β in the observation group was higher than that in the control group, and the serum levels of sIL-2R, IL-17 and IL-8 in the observation group were lower than those in the control group (P<0.05).【Conclusion】 Omeprazole combined with clarithromycin and metronidazole in the treatment of Helicobacter pylori associated gastritis in children has significant effect, which can reduce the inflammatory reaction and improve the immune function.
|
Received: 19 June 2018
|
|
|
|
|
[1] 林茂增,郑志宏.小儿消化性溃疡的临床特点及与胃镜特征关系研究[J].中国实验诊断学,2017,21(1):42-44. [2] 鄢富贵,张杨,温冬香,等.幽门螺杆菌感染和小儿缺铁性贫血的相关性分析[J].现代医院,2017,17(8):1207-1209. [3] 方座华,李哲.三联疗法治疗小儿消化性溃疡的临床价值[J].沈阳医学院学报,2017,19(4):333-335. [4] 中华医学会消化病学分会.中国慢性胃炎共识意见[J].胃肠病学,2006,11(11):674-684. [5] 孟玉梅,孔锐,宋媛,等.苏州城区婴幼儿幽门螺杆菌感染危险因素研究[J].中国儿童保健杂志,2017,25(11):1156-1159. [6] 宗海生.克拉霉素联合替硝唑治疗小儿幽门螺杆菌相关性胃炎43例[J].实用中西医结合临床,2017,17(8):83-84. [7] 甄劲争.以奥美拉唑为主的三联疗法治疗小儿消化性溃疡对疗效及复发率的影响[J].实用妇科内分泌电子杂志,2017,4(24):129-130. [8] Abbas M, Sharif FA, Osman SM, et al. Prevalence and associated symptoms of helicobacter pylori infection among schoolchildren in Kassala State, East of Sudan[J].Interdiscip Perspect Infect Dis,2018, 18(12):1-5. [9] 谢秋云.阿莫西林与莫西沙星治疗幽门螺旋杆菌胃病的临床疗效及药理学分析[J].北方药学,2016,13(4):173-174. [10] 刘雪芳,马岚青.幽门螺旋杆菌对克拉霉素、甲硝唑、左氧氟沙星耐药的研究进展[J].胃肠病学和肝病学杂志,2016,25(1):101-104. [11] 伍鸣杰.克拉霉素为主的三联疗法治疗小儿幽门螺旋杆菌阳性消化性溃疡的效果评价[J].中国医药科学,2017,7(18):62-64. [12] 张海莲,朱云,刘军权,等.幽门螺旋杆菌引起胃黏膜免疫损伤机制研究进展[J].国际免疫学杂志,2017,40(2):204-209. [13] 刘晗.标准三联疗法治疗老年幽门螺旋杆菌胃炎的疗效及其对血清白细胞介素及转化生长因子水平的影响[J].中国老年学杂志,2017,37(6):1437-1438. [14] 严海,胡清林,青廉,等.参芪扶正注射液联合胃复春对慢性萎缩性胃炎患者血清胃泌素、可溶性白介素-2受体及免疫功能影响[J].实用临床医药杂志,2017,21(13):174-175. [15] 姜源,胡凤蓉,田莉,等.奥美拉唑联合柴胡疏肝散对胃溃疡患者血清NF-κB及IL-8表达的影响[J].现代生物医学进展,2018,18(4):775-778. |
[1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(8): 1121-1123. |
|
|
|
|